707.06歐元8.16(1.14%)
2021/03/05更新
績效 / 1月11.08%
3月0.36%
1年11.62%
晨星評等 - 1.現金3.32%
- 2.股票6.71%
- 3.債券0.50%
- 4.其他89.47%
- 1.美國89.47%
- 2.加拿大3.00%
- 3.新興亞洲2.10%
- 4.英國1.02%
- 5.歐洲不包含歐元區0.38%
- 1.Biogen Inc5.79%
- 2.Vertex Pharmaceuticals Inc Ordinary Shares5.76%
- 3.Amgen Inc Ordinary Shares5.55%
- 4.Gilead Sciences Inc Ordinary Shares5.44%
- 5.Alexion Pharmaceuticals Inc Ordinary Shares4.60%
- 6.Seagen Inc Ordinary Shares4.06%
- 7.Regeneron Pharmaceuticals Inc Ordinary Shares4.03%
- 8.Novavax Inc Ordinary Shares3.21%
- 9.Neurocrine Biosciences Inc Ordinary Shares3.03%
- 10.Exelixis Inc Ordinary Shares2.82%
- 1.現金3.32%
- 2.股票6.71%
- 3.債券0.50%
- 4.其他89.47%
- 1.美國89.47%
- 2.加拿大3.00%
- 3.新興亞洲2.10%
- 4.英國1.02%
- 5.歐洲不包含歐元區0.38%
- 1.Biogen Inc5.79%
- 2.Vertex Pharmaceuticals Inc Ordinary Shares5.76%
- 3.Amgen Inc Ordinary Shares5.55%
- 4.Gilead Sciences Inc Ordinary Shares5.44%
- 5.Alexion Pharmaceuticals Inc Ordinary Shares4.60%
- 6.Seagen Inc Ordinary Shares4.06%
- 7.Regeneron Pharmaceuticals Inc Ordinary Shares4.03%
- 8.Novavax Inc Ordinary Shares3.21%
- 9.Neurocrine Biosciences Inc Ordinary Shares3.03%
- 10.Exelixis Inc Ordinary Shares2.82%